Kjell Göran Stenberg
Amministratore Delegato presso CYXONE AB
Provenienza dei contatti di primo grado di Kjell Göran Stenberg
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.
22
| Subsidiary | Miscellaneous Commercial Services | 22 |
Astra AB
Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden.
13
| Extinct | Pharmaceuticals: Major | 13 |
Medwell Capital Corp.
Medwell Capital Corp. Investment ManagersFinance Medwell Capital Corp. operates as an investment and advisory firm which directly invests in and advises companies on strategy and corporate and technology development. It also provides clinical, regulatory and corporate advisory services. The company was founded on December 15, 1998 and is headquartered in Edmonton, Canada.
8
| Extinct | Investment Managers | 8 |
Galecto Biotech ApS
Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Public Company | Pharmaceuticals: Major | 8 | |
Novation Pharmaceuticals, Inc.
Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novation Pharmaceuticals, Inc. operates as a biotechnology research and development company. It provides modulation of intracellular messenger RNA (mRNA) to identify new small-molecule therapies to treat serious diseases. The company was founded by Dominique Cheneval and Tania Kastelic and is headquartered in Burnaby, Canada.
5
| Private Company | Medical/Nursing Services | 5 |
Public Company | Biotechnology | 4 | |
Aptahem AB
Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden.
3
| Public Company | Pharmaceuticals: Major | 3 |
Accequa AB
1
| Private Company | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kjell Göran Stenberg tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Director/Board Member Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Investor Relations Contact | |
INVESTOR AB | Financial Conglomerates | Director/Board Member Director/Board Member | |
ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer President | |
NOVO NORDISK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
TAURUS ENERGY AB | Oil & Gas Production | Director/Board Member Director/Board Member | |
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member | |
BIOINVENT INTERNATIONAL AB | Biotechnology | Chief Executive Officer Director/Board Member Chief Executive Officer | |
MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chairman Founder | |
RECIPHARM AB (PUBL) | Biotechnology | Director of Finance/CFO Director/Board Member Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
OREXO AB | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Stockholm School of Economics | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
University of Uppsala | College/University | Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
University of Stockholm | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Royal Institute of Technology | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
University of Lund | College/University | Director/Board Member Doctorate Degree Doctorate Degree Undergraduate Degree | |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Chairman Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
BONESUPPORT HOLDING AB | Medical Specialties | Director of Finance/CFO Director/Board Member | |
Astra Arcus AB | Corporate Officer/Principal Corporate Officer/Principal | ||
Dilafor AB
Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member | |
Beactica Therapeutics AB
Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Medical Distributors | Director/Board Member Director/Board Member | |
Astra Hässle AB | Chief Executive Officer Director/Board Member | ||
WNTRESEARCH AB | Pharmaceuticals: Other | President Chief Executive Officer | |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Recipharm Stockholm AB | Director/Board Member Chairman Director/Board Member | ||
Recipharm Strängnäs AB
Recipharm Strängnäs AB Miscellaneous Commercial ServicesCommercial Services Part of Recipharm AB, Recipharm Strängnäs AB is a contract development and manufacturing organization in the pharmaceutical industry. The company is based in Strängnäs, Sweden. Founded in 2004, Recipharm Strängnäs operates as a contract development and manufacturing organization in the pharmaceutical industry. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Recipharm Karlskoga AB
Recipharm Karlskoga AB Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm Karlskoga AB is a Swedish pharmaceutical company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Director/Board Member Chairman | |
NovaSAID AB
NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Attgeno AB
Attgeno AB Pharmaceuticals: MajorHealth Technology ATTGENO AB develops, manufactures, and trades pharmaceutical drugs and electronic apparatus. Its product, Supernitro, is a vasodilator indicated for the treatment of acute pulmonary hypertension associated with major cardiac surgery. The company is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director of Finance/CFO Chairman | |
EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
Swedish Pharmaceutical Society | Chairman Chairman | ||
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Director/Board Member Chief Investment Officer Chief Operating Officer | |
Palette Life Sciences AB
Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
MENDUS AB | Biotechnology | Director/Board Member Chairman | |
Swedish Academy For Pharmaceutical Sciences | Corporate Officer/Principal Chairman | ||
Ideonfonden AB | Director/Board Member Chief Executive Officer | ||
BONE SUPPORT AB
BONE SUPPORT AB Medical SpecialtiesHealth Technology BONE SUPPORT AB manufactures orthopedic supplies and equipment. Its products include cerament bone void filler, cerament G with gentamicin, cerament V with vancomycin. The company was founded by Lars Ake Alvar Lidgren in 1999 and is headquartered in Lund, Sweden. | Medical Specialties | Director of Finance/CFO Director/Board Member | |
SYNACT PHARMA AB | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
GABATHER AB | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member Founder Director of Finance/CFO | |
DICOT PHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
ANNEXIN PHARMACEUTICALS AB | Pharmaceuticals: Major | Chairman Director/Board Member | |
GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member Chief Operating Officer Director/Board Member Director/Board Member | |
Galecto Biotech AB | Chairman Founder Founder | ||
Accequa GmbH | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
Svezia | 44 |
Stati Uniti | 4 |
Regno Unito | 2 |
Danimarca | 2 |
Canada | 2 |
Settori
Health Technology | 27 |
Consumer Services | 7 |
Commercial Services | 5 |
Finance | 3 |
Energy Minerals | 2 |
Posizioni
Director/Board Member | 505 |
Corporate Officer/Principal | 164 |
Chairman | 134 |
Independent Dir/Board Member | 90 |
Chief Executive Officer | 70 |
Contatti più connessi
- Borsa valori
- Insiders
- Kjell Göran Stenberg
- Connessioni Società